Hyphens Pharma announced on Jan 7, that its subsidiary, Pan-Malayan Pharmaceuticals has been awarded with an e-pharmacy licence for WellAway Pharmacy by the Health Sciences Authority (HSA).

WellAway Pharmacy aims to leverage on Pan-Malayan’s medical and logistical expertise, to work closely with medical clinics in Singapore in providing reliable and convenient medication delivery services to residential homes.

 “With the rise of telemedicine redefining healthcare systems all over the world, e-pharmacy and home delivery services have become increasingly important to ensure that patients receive essential medications on time. We hope WellAway will contribute to the evolving development of telemedicine in Singapore,” says Lim See Wah, executive officer and CEO of Hyphens Pharma.

Shares in Hyphens Pharma closed 1 cent higher or 3.2% up at 32.5 cents on Jan 7.